Merck Announces Health Canada Approval of ENFLONSIA® for the prevention of RSV in newborns and infants
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline
Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans
KEYTRUDA® Plus Padcev® Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response Rates for Cisplatin-Eligible Patients with MIBC When Given Before and After Surgery
Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR in Adults with Pulmonary Arterial Hypertension
FDA Conditionally Approves Merck Animal Health's EXZOLT CATTLE-CA1 for the Prevention and Treatment of New World Screwworm Larvae
Merck Data to be Presented at ASH 2025 Annual Meeting Showcase Continued Advancements in Hematology Pipeline and Novel Therapeutic Approaches
Tartisan Nickel Corp. Appoints Jack Jacobs, Congressional Medal of Honour Recipient, Retired Army Colonel and Distinguished Business Executive to Board of Advisors
